======= TFRC ======= == Gene Information == * **Official Symbol**: TFRC * **Official Name**: transferrin receptor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7037|7037]] * **UniProt**: [[https://www.uniprot.org/uniprot/P02786|P02786]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TFRC&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TFRC|Open PubMed]] * **OMIM**: [[https://omim.org/entry/190010|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]. * **UniProt Summary**: Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site. Positively regulates T and B cell proliferation through iron uptake (PubMed:26642240). {ECO:0000250, ECO:0000269|PubMed:26642240, ECO:0000269|PubMed:3568132}. |Peptidase M28| |PA| |TFR dimer| |transferrin receptor activity| |HFE-transferrin receptor complex| |positive regulation of bone remodeling| |positive regulation of bone resorption| |positive regulation of isotype switching| |positive regulation of tissue remodeling| |regulation of isotype switching| |transferrin transport| |positive regulation of immunoglobulin mediated immune response| |positive regulation of B cell mediated immunity| |positive regulation of DNA recombination| |regulation of bone resorption| |positive regulation of B cell proliferation| |positive regulation of immunoglobulin production| |osteoclast differentiation| |regulation of bone remodeling| |regulation of immunoglobulin mediated immune response| |regulation of B cell mediated immunity| |clathrin-coated vesicle membrane| |clathrin-coated pit| |extracellular vesicle| |regulation of B cell proliferation| |receptor internalization| |cellular iron ion homeostasis| |regulation of immunoglobulin production| |iron ion transport| |double-stranded RNA binding| |regulation of tissue remodeling| |virus receptor activity| |iron ion homeostasis| |positive regulation of T cell proliferation| |viral entry into host cell| |response to leukemia inhibitory factor| |positive regulation of production of molecular mediator of immune response| |cellular response to leukemia inhibitory factor| |positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |melanosome| |entry into host cell| |entry into host| |regulation of DNA recombination| |positive regulation of adaptive immune response| |positive regulation of lymphocyte mediated immunity| |receptor metabolic process| |cellular transition metal ion homeostasis| |myeloid leukocyte differentiation| |recycling endosome| |transition metal ion transport| |positive regulation of lymphocyte proliferation| |transition metal ion homeostasis| |positive regulation of mononuclear cell proliferation| |positive regulation of leukocyte mediated immunity| |positive regulation of leukocyte proliferation| |regulation of production of molecular mediator of immune response| |blood microparticle| |regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |regulation of lymphocyte mediated immunity| |interaction with host| |regulation of T cell proliferation| |regulation of adaptive immune response| |positive regulation of B cell activation| |positive regulation of DNA metabolic process| |basolateral plasma membrane| |viral life cycle| |positive regulation of T cell activation| |regulation of leukocyte mediated immunity| |regulation of B cell activation| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |endosome membrane| |positive regulation of leukocyte cell-cell adhesion| |positive regulation of immune effector process| |myeloid cell differentiation| |regulation of leukocyte proliferation| |receptor-mediated endocytosis| |cytoplasmic vesicle| |positive regulation of cell-cell adhesion| |early endosome| |endosome| |regulation of leukocyte cell-cell adhesion| |regulation of T cell activation| |leukocyte differentiation| |regulation of DNA metabolic process| |positive regulation of lymphocyte activation| |external side of plasma membrane| |regulation of cell-cell adhesion| |cellular response to drug| |positive regulation of cell adhesion| |positive regulation of leukocyte activation| |regulation of cell growth| |positive regulation of cell activation| |regulation of immune effector process| |regulation of lymphocyte activation| |endocytosis| |cellular metal ion homeostasis| |hemopoiesis| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |cell surface| |metal ion homeostasis| |cellular cation homeostasis| |metal ion transport| |regulation of cell activation| |cellular ion homeostasis| |immune system development| |regulation of growth| |import into cell| |regulation of cell adhesion| |perinuclear region of cytoplasm| |viral process| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |symbiotic process| |ion homeostasis| |interspecies interaction between organisms| |cation transport| |membrane organization| |positive regulation of immune response| |protein homodimerization activity| |cellular homeostasis| |positive regulation of cell population proliferation| |cellular response to cytokine stimulus| |response to drug| |identical protein binding| |response to cytokine| |chemical homeostasis| |regulation of immune response| |positive regulation of immune system process| |positive regulation of developmental process| |ion transport| |RNA binding| |integral component of plasma membrane| |protein transport| |peptide transport| |amide transport| |extracellular space| |establishment of protein localization| |regulation of cell population proliferation| |homeostatic process| |regulation of immune system process| |positive regulation of multicellular organismal process| |nitrogen compound transport| |positive regulation of nucleobase-containing compound metabolic process| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp346|CoCl2 18μM R07 exp346]]|-2.66| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-2.12| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.96| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.72| |[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|1.85| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|2| |[[:results:exp133|MKC9989 10μM R03 exp133]]|2.09| |[[:results:exp115|A-366 10μM R03 exp115]]|2.71| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|3.02| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.508| |[[:human genes:c:cyb561a3|CYB561A3]]|0.487| |[[:human genes:d:dnm2|DNM2]]|0.424| |[[:human genes:r:rpl7l1|RPL7L1]]|0.416| |[[:human genes:p:prim1|PRIM1]]|0.415| |[[:human genes:s:sf3a3|SF3A3]]|0.407| |[[:human genes:s:sf3b1|SF3B1]]|0.405| |[[:human genes:f:fancm|FANCM]]|0.404| |[[:human genes:m:mak|MAK]]|0.402| Global Fraction of Cell Lines Where Essential: 417/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|18/28| |blood|27/28| |bone|7/26| |breast|27/33| |central nervous system|8/56| |cervix|1/4| |colorectal|12/17| |esophagus|5/13| |fibroblast|0/1| |gastric|13/16| |kidney|14/21| |liver|6/20| |lung|44/75| |lymphocyte|15/16| |ovary|11/26| |pancreas|18/24| |peripheral nervous system|7/16| |plasma cell|12/15| |prostate|0/1| |skin|16/24| |soft tissue|3/9| |thyroid|1/2| |upper aerodigestive|11/22| |urinary tract|14/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17 * **Expression level (log2 read counts)**: 10.48 {{:chemogenomics:nalm6 dist.png?nolink |}}